How to Buy Xoma Royalty Stock
Xoma Royalty Corp
XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health.
Xoma Royalty stock last closed at $25.22, down 4.97% from the previous day, and has decreased 10.02% in one year. It has overperformed other stocks in the Biotechnology industry by 0.35 percentage points. Xoma Royalty stock is currently +37.42% from its 52-week low of $18.35, and -36.82% from its 52-week high of $39.92.
As of Dec 12, 2025, there are 12.38M XOMA shares outstanding. The market cap of XOMA is $312.30M. In the last 24 hours, 134,000 XOMA shares were traded.
How to Buy Xoma Royalty Stock
Not sure how to invest in Xoma Royalty stock? Here's how.
- Figure out where to buy Xoma Royalty stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you choose where to buy Xoma Royalty stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Choose your payment method and add your details.
- Evaluate Xoma Royalty stock: The Xoma Royalty ticker symbol is XOMA. Is Xoma Royalty stock a good investment? Should you buy shares of XOMA? How do XOMA's underlying business fundamentals look? Do top analysts think Xoma Royalty is a good buy? Why has XOMA's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if XOMA is a good stock to buy).
- Execute your XOMA buy order: Decide if you will purchase XOMA shares at the current market price or use a limit order to purchase XOMA stock at a specific price.
- Keep tabs on your XOMA position: Create a watchlist to keep tabs on your investment in Xoma Royalty shares.
Step 1: Figure out where to buy Xoma Royalty stock
You will need a brokerage account in order to access the NASDAQ market and buy XOMA stock.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, you need to fill out some personal details so you are able to invest in XOMA today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create a new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on the best stock app for beginners, your next step is to transfer the money for your investment:
Check out the video below if you need help depositing funds into your investment account.
Step 4: Evaluate Xoma Royalty stock
After you have selected the best place to buy Xoma Royalty stock, it's crucial to research their stock prior to buying, so you truly wrap your head around the risk as well as the opportunity.
Overview of key XOMA info
Fundamentals of Xoma Royalty
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on XOMA's stock page.
Is XOMA stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge XOMA's true value.
Using relative valuations metrics:
- XOMA could be undervalued based on its P/E ratio of 31.14x, relative to Biotechnology industry P/E ratio of 155.66x
- XOMA may be undervalued based on its P/B ratio of 3.55x, relative to Biotechnology industry P/B ratio of 5.32x
You can access additional valuation research on XOMA's stock here.
XOMA Financial Health
Signs that XOMA is financially healthy:
- XOMA has $92.00M in cash and short term investments. This is sufficient to cover its annual cash burn of $12.41M.
- XOMA profit margin has gone up from -171.7% to 35.2% in the past year.
- XOMA has cash burn of 12410000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the XOMA balance sheet.
Signs that XOMA is not financially healthy:
- XOMA has a relatively high debt to equity ratio of 1.77.
- There are more long-term liabilities than short-term assets on the XOMA balance sheet.
- Total XOMA debt is higher than 5 years ago, relative to shareholder equity.
Is XOMA stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 3 Equities analysts who research XOMA, the consensus analyst rating on XOMA is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Xoma Royalty stock forecast page.
XOMA Momentum
XOMA Revenue
Last year, XOMA earnings were $16.60M. Over the past four year, XOMA's earnings have gone up by 43.69% per year. This was faster than the Biotechnology industry average of 10.76%.
Last year, XOMA revenue was $47.11M. During the past five year, XOMA's revenue has grown by 84.11% per year. This was faster than the Biotechnology industry average of 43.8%.
You can research XOMA's earnings and revenue performance here.
Are XOMA executives and large shareholders buying or selling the stock?
Over the past year, executives and large shareholders at XOMA have sold more shares than they have bought.
Owen Hughes, Chief Executive Officer of XOMA, was the latest XOMA insider to buy. They bought $2,505,000.00 worth of XOMA shares on Dec 4, 2025.
Get more info about who owns XOMA shares here.
Does XOMA provide a stable income stream?
No, Xoma Royalty doesn't provide an income stream by paying out dividends.
XOMA Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your XOMA buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular price, place a limit order.
Click the Open button and eToro will place the order.
If you want additional info about buying stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your XOMA position
Now that you own some XOMA shares, you'll want to keep up with your shares.
Make a watchlist to see the latest developments about your XOMA stock.
XOMA Feed
How to Buy Stock in Xoma Royalty
To summarize, here are the 6 steps to buy Xoma Royalty stock:
- Figure out where to buy Xoma Royalty stock
- Sign up for your brokerage account
- Deposit funds into your investment account
- Evaluate Xoma Royalty stock
- Execute your XOMA buy order
- Keep tabs on your XOMA position
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep tabs on your investment in Xoma Royalty, click the button below.
Other "How To" Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.